{"data":{"id":"us-in/ic-25-1-22-4","jurisdiction":"us-in","citation":"IC 25-1-22-4","heading":"\"Gender transition hormone therapy\"","body":"Sec. 4. As used in this chapter, \"gender transition hormone therapy\" means:\n(1) testosterone;\n(2) estrogen; or\n(3) progesterone;\ngiven to an individual in an amount greater than would normally be produced endogenously in a healthy individual of that individual's age and sex.","path":["TITLE 25. PROFESSIONS AND OCCUPATIONS","ARTICLE 1. GENERAL PROVISIONS","Chapter 22. Gender Transition Procedures for Minors"],"source_url":"https://iga.in.gov/ic/2026/Title_25.html#25-1-22-4","current_through":"2026","vintage":"2026","retrieved_at":"2026-10-06T20:43:28Z","sha256":"902272d112374d31e5a395db45022226395f9ea35db5fb7dd76420524c00d04f","source_id":"us-in","stale":false,"prev":"us-in/ic-25-1-22-3","next":"us-in/ic-25-1-22-5"},"notice":"GroundRules: Original legal text. Not legal advice."}
